Wednesday, March 10, 2021

Investorideas.com - The Green Organic Dutchman Reports Fourth Quarter and Year End 2020 Financial Results

Investorideas.com - The Green Organic Dutchman Reports Fourth Quarter and Year End 2020 Financial Results

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 540 (TSX: $TGOD.TO) (OTC: $TGODF) (TSX: $FAF.TO) (OTCQX: $FFLWF) (CSE: $MEDI.C)

 



 

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 540 (TSX: $TGOD.TO) (OTC: $TGODF) (TSX: $FAF.TO) (OTCQX: $FFLWF) (CSE: $MEDI.C)

 

Delta, Kelowna, BC, March 10, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/031021-StocksToWatch.mp3

 

Read this in full at  https://www.investorideas.com/news/2021/cannabis-potcasts/03101TGOD-FAF-MEDI.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public and private company announcements.

 

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a leading producer of premium certified organically grown cannabis, reports its results for the fourth quarter and fiscal year ended December 31, 2020. These filings are available for review on the Company's SEDAR profile at www.sedar.com.

 

Some of the financial highlights included:

       Fourth quarter revenue of $10.92 million, a 91% increase quarter-over-quarter

       Canadian cannabis revenue of $8.55 million for the quarter, an increase of 122% over the prior quarter

       G&A reduction of 59% compared to the same period in 2019

       Full year revenue of $24.51 million, a 120% increase year-over-year

 

 

The Company announced that its board of directors has appointed Sean Bovingdon as Chief Executive Officer (CEO), and member of the board, effective immediately. Mr. Bovingdon had previously been appointed as Interim CEO in November 2020 while continuing to serve as CFO. He will continue as interim CFO while the Company undertakes a search for a permanent Chief Financial Officer.

 

"Sean has been very effective in leading the company through these extremely challenging past few months. He stepped into the interim-CEO position and has demonstrated outstanding leadership," stated Jeff Scott, Chairman of the board. "Sean has the strategic vision and experience to effectively guide TGOD through its next phase of growth. On behalf of the board of directors, I am very pleased to appoint Sean as CEO of the company."

 

"We delivered strong growth in 2020 thanks to the expansion of our product assortment, including the launch of Highly Dutch, and continuous improvements to our supply chain.  This accomplishment, realized against a challenging backdrop, reflects the quality of our products, underpinned by our talented and committed team," commented Sean Bovingdon, TGOD's CEO and interim CFO.

 

"We remain laser-focused on operational execution as we chart the course for future growth, including opportunities in Europe, Mexico and the United States. We remain optimistic about the Company's financial prospects but envision a path forward where continued financial discipline will play a key role. While our Canadian facilities continue to remain open as providing an essential service to our customers during the COVID-19 pandemic, we note several retailers were not able to remain fully open especially during Q1-2021, and therefore we expect a delay in the rate of growth until at least Q2-2021. Our recently launched Organic Sugar Bush, a high-THC Sativa variety, reflecting the quality and potency improvements we have achieved, and our new Hash SKUs are expected to provide an added boost to our sales mix in the coming months." added Bovingdon.

 

Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF), a leading cannabis retailer with a proprietary digital retail and data platform, today announced that its wholly-owned indirect subsidiary, Hifyre Inc., has entered into a strategic agreement with BDS Analytics Inc. to incorporate Hifyre's Canadian digital retail and analytics into BDSA's existing online U.S.-based market research platform. As part of the agreement, BDSA will offer Hifyre IQ™ Canadian cannabis data to its U.S.-based clients and Hifyre™ will be able to provide U.S. data from BDSA to its Canadian clients, allowing both companies to offer enhanced, crossborder data to their respective consumer bases.

 

Matthew Hollingshead, President of Hifyre, Inc., commented, "A key aspect of Fire & Flower's growth strategy is to strategically incorporate alternative high-margin revenue streams into our business model in order to drive profitability, while building a leadership role in key cannabis markets around the world.  Our Hifyre IQ™ analytics platform has proven successful in Canada as it has presented one of the strongest avenues of high-margin growth for our business and is recognized by licensed cannabis producers, equity research analysts, investment banks, hedge funds and consulting firms as a leading cannabis data platform in the country. Extending this platform into the U.S. is an excellent opportunity to accelerate this revenue stream."

 

Hollingshead continued, "Our unique Hifyre IQ™ platform has generated widespread demand from other leading cannabis companies looking to efficiently capture consumer data and meet customer demand. BDSA's extensive U.S. cannabis database and ability to quickly adapt to changing regulations in the U.S. makes them a prime partner.  Through this agreement, both Fire & Flower and BDSA anticipate enlarging our respective consumer bases while supporting each other's continued growth in the cannabis industry."

 

Greenline announced its new financing service, Greenline Capital, a platform providing fast and easy access to short-term capital for cannabis retailers using the Greenline platform. The platform offering is supported by Merchant Growth Ltd., a leader in providing financing solutions to small businesses in Canada.

 

"Due to the classification of cannabis retail as 'high-risk', one of the biggest barriers to growth in our industry is access to capital," said Calvin Ho, COO of Greenline. "That's why we're introducing Greenline Capital to help cannabis retailers grow their businesses."

We understand that the Canadian cannabis industry is not high risk - retailers sell highly regulated products in government-licensed locations with predictable high demand. This is why Greenline is collaborating with Merchant Growth to offer two new services through Greenline Capital for Greenline customers: short-term financing and lines of credit. "We are pleased to partner with Greenline POS to offer a unique financing solution to its growing customer base," said Aidan Vaandering, Director of Business Development of Merchant Growth.

 

Provided a business has at least 3 to 6 months of business history, Greenline customers can be approved in 24 hours for up to $500,000 CAD in financing with flexible repayment terms, and up to a $125,000 CAD line of credit.

 

"This amount of capital could be a game-changer for cannabis retailers looking to expand into multiple locations, or simply have a line of credit ready for financing purchase orders and marketing," said Albert Kim, CEO of Greenline. "We have heard many times from our rapidly growing customer base that access to capital has been one of the most frustrating roadblocks to expanding their businesses. Greenline Capital is designed to solve this problem."

 

Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDIannounced that the Company has entered into a letter of intent for the acquisition of all of the issued and outstanding shares of Mindscape Ketamine & Infusions Therapy, PLLC, a mental health and pain clinic based in Houston, Texas.

 

Mindscape was founded by Dr. Quang Henderson, an experienced emergency medicine physician who earned his MD credential and completed his residency at the University of Texas. Prior to founding Mindscape in 2018, Dr. Henderson was a Co-Founder of Neighbors Emergency Center, a network of emergency care facilities in Texas which currently has six locations. After ketamine-based treatments helped to alleviate depression-related symptoms experienced by his wife, Dr. Henderson was inspired to open Mindscape to avail such treatments to the general public. The Houston-based clinic, which administers ketamine through intravenous therapy (“IV”), is characterized by its spa-like atmosphere designed to put patients at ease. The Mindscape patient experience is augmented by a selection of multimedia including music and tailored virtual reality (“VR”) content which are intended to enhance the effects of a ketamine dosage.

 

Ketamine was first synthesized in 1962, and was successfully patented as a human anaesthetic in the United States in 1966. During the Vietnam War, ketamine was the most widely used battlefield anaesthetic, and has been listed in the World Health Organization’s Essential Medicines List since 1985. Usage of ketamine in veterinary medicine began in the 1970s, and it is presently the most widely used anaesthetic in this area of medicine1. In 2000, research conducted at Yale University determined that in a sample group of patients with major depression, the improvement in their symptoms realized within 72 hours could qualify the drug for use as an antidepressant. These findings were complemented six years later by a National Institutes of Mental Health (“NIMH”) study which showed that ketamine reduced depression symptoms more quickly than a placebo2.

 

As ketamine continues to gain popularity as a treatment for a variety of conditions, Myconic treats its acquisition of Mindscape as a strategic investment with which the Company can build out its holdings in the health and wellness category.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Tuesday, March 9, 2021

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: $EMH) Announces Intention to List on Canadian Securities Exchange

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: $EMH) Announces Intention to List on Canadian Securities Exchange

Investor Ideas #Potcasts 539, #Cannabis News and #Stocks on the Move; (CSE: $LOWL.C) (CSE: $PULL.C) (TSX: $VLNS.TO) (OTCQX: $VLNCF) (CSE: $AUSA.C)

 



 

Investor Ideas #Potcasts 539, #Cannabis News and #Stocks on the Move; (CSE: $LOWL.C) (CSE: $PULL.C) (TSX: $VLNS.TO) (OTCQX: $VLNCF) (CSE: $AUSA.C)

 

Delta, Kelowna, BC, March 9, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/030921-Mining.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/03091LOWL-PULL-VLNS-AUSA.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Lowell Farms Inc. (CSE: LOWL) (OTCQX: LOWLF), a leading, vertically-integrated, California-focused cannabis company, has completed its previously announced corporate name change following the acquisition by Indus Holdings, Inc. of Lowell Farms. The combined company is now operating under the Lowell Farms Inc. name.

 

The Company's Subordinate Voting Shares and Warrants are now trading on the Canadian Securities Exchange under the ticker symbols LOWL and LOWL.WT  and the Subordinate Voting Shares are now trading on the OTCQX under the ticker symbol LOWLF.  No action is required to be taken by existing securityholders of the Company with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.

 

"We are hard at work pairing-up the best brand in cannabis with unparalleled production capabilities," says Lowell Farms Chairman George Allen. "By combining Indus' infrastructure and capabilities with Lowell's brand leadership, we are building a business that has no equal in cannabis."

 

Adds Lowell Farms Chief Executive Officer Mark Ainsworth: "The integration of Lowell products in our distribution network has already begun to show positive results, and we are scaling operations to meet the demand for our marquee products. We now control our own destiny and look forward to better showcasing the strength of our company in 2021 and beyond."

 

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, announced that it has signed a Letter of Intent (LOI) with ShroomBloom Labs/Floja Bioscience Inc. (“ShroomBloom”) to enter into an agreement for the supply of psychedelic mushroom biomass.

 

ShroomBloom is a British Columbia based mushroom cultivator whose unique growing method uses a sustainable forest product to grow organic Psilocybe Azurescens mushrooms. Also known as Azures, they are native to British Columbia and are one of the most potent psilocybin mushrooms that have ever been found. Azures contain up to 1.8% psilocybin, 0.5% psilocin, and 0.4% baeocystin by dry weight - nearly three times more than the more common Psilocybe Cubensis mushrooms. ShroomBloom is currently conducting a bio-tech research and development program utilizing artificial intelligence (AI) to industrialize the cultivation of psychedelic mushrooms. Their goal is to become the global leader in the production of psilocybin mushrooms.

 

Under the terms of the LOI, Pure Extracts would get preferential access to ShroomBloom’s crop of psychedelic mushrooms and would get ‘most favoured nation’ pricing. The LOI is subject to both ShroomBloom and Pure Extracts holding Dealer's Licences under the Controlled Drugs and Substances Act (CDSA).

 

Pure Extracts CEO, Ben Nikolaevsky, remarked, “A supply agreement with a world-class cultivator like ShroomBloom would ensure a reliable source of high-quality, high-potency, psychedelic mushroom biomass for our extraction facility so that we can produce plenty of psilocybin for our formulation R&D activities and for any resulting clinical trials.”

 

The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, announced the closing of its previously announced acquisition of all of the issued and outstanding shares of LYF Food Technologies Inc. The cash and share transaction totaled CDN$24.9 million payable on closing, plus approximately CDN$17.5 million in post-closing consideration subject to achieving certain earn-out EBITDA milestones. With this acquisition of LYF, Valens has accelerated its footprint in the edibles category, which is one of the fastest-growing segments of the Cannabis 2.0 and 3.0 markets.

 

Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company, said: "We are incredibly excited to officially welcome LYF to the Valens family, which will undoubtedly strengthen our manufacturing leadership position given their confectionary expertise and broad network of partners and retailers. The closing of the LYF acquisition, and the addition of their leading edibles platform, signifies the completion of a key milestone in our strategy to drive SKU growth in new product categories and maximize market share gains across the country. We have already begun diversifying our product offering with the launch of various soft chews manufactured in LYF's facility, and we have a strong pipeline of new innovative edible products we believe will increase both quality and variety in the existing edibles segment in Canada today."

 

Paolo Pero and Matthew Amado, Co-Founders of LYF, said: "We are ready to hit the ground running with the Valens team as a unified manufacturing force in the Canadian recreational market. Our shared passion for putting consumers at the forefront of product development, formulation and commercialization will be demonstrated as we begin rolling out various edible products that the Canadian market has never seen before."

 

With the addition of the LYF facility, the Company now has the capability to produce a wide range of edible products in various formats and dosages as part of its central platform. The added product development and manufacturing flexibility makes the platform easily adaptable to evolving consumer preferences and changing market regulations around edible products as Valens looks to expand both in Canada and globally. Additionally, Valens welcomes several new team members who have gained valuable experience working in the confectionary, commercial-scale food manufacturing and cannabis industries, and bring with them the knowledge to produce unique and expected higher-margin products such as honey, granola balls, baked goods, and various gourmet gummy and chocolate formats. Vegan, sugar-free and low-sugar formats are available and will be especially complementary to the development of Valens' health and wellness product suite.

 

In the first quarter of 2021, Valens and LYF launched edible products with shared partners A1 Cannabis Co. ("A1 Cannabis") and Verse Cannabis ("Verse"). In partnership with A1 Cannabis, LYF launched the Summit Wild Berry Soft Chews, made with real-fruit juice, no added colours or flavours and 5mg of THC per soft chew. Additionally, The Valens Company and Verse Cannabis launched Verse Soft Chews – a new line of edible formulations and unique flavors at a great value. The new product lineup includes Verse Baked Apple Soft Chews, infused with flavours of green apple and cinnamon offering a tart-meets-sweet flavour bite, and Verse Sour Medley Soft Chews, a variety pack of five sweet and sour flavours, including green apple, raspberry, watermelon, pineapple, and cherry. Each pouch contains five soft chews each with approximately 2mg of THC and formulated with Valens' premium cannabis distillate. The Verse Baked Apple Soft Chews are now available in Alberta and are expected to be available shortly in British Columbia and Ontario, while the Verse Sour Medley Soft Chews will be available in the coming weeks in Alberta and British Columbia.

 

The Valens Company expects to ramp up shipments of edible products to provincial retailers in the coming weeks, including existing SKUs such as Citizen Stash Strawberry Mac gummies from LYF's white label agreement with Experion Biotechnologies Inc. In the second quarter of fiscal 2021, the Company intends to launch an assortment of unique, consumer-driven edible products into the market.

 

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAFtoday announced that, further to its press releases dated January 5, 2021 and February 24, 2021, the Company has completed the acquisition of a 51% ownership interest in 2750176 Ontario Inc. ("ALPS") for initial consideration of $10,000,000 in shares of the Company and cash of $2,000,000. With the transaction comes the option for AUSA to acquire the remaining 49% on the terms summarized in the Company's January 5th press release. One of the conditions of the transaction is that Mr. Terry Booth has been appointed the Company's CEO, effective immediately. Mr. Booth has also been appointed to the AUSA board of directors. Dr. Duke Fu, who had been serving as the Company's Interim CEO since the November 2020 leadership transition, has been appointed the Company's COO. Dr. Fu will remain on the AUSA board of directors.

 

With the transaction, AUSA is acquiring a majority interest in ALPS, the global leader in facility design, construction management and (post) commissioning services to the horticultural sector across a wide variety of commercial crops, including cannabis, fruits, vegetables, mushrooms and ornamentals. ALPS is also a foundational piece in the Company's unique expansion strategy.

 

As announced on January 5, 2021, with the closing of the ALPS transaction, ALPS principal and former CEO of Aurora Cannabis Inc., Terry Booth, effective immediately, has been appointed CEO at Australis, replacing Dr. Duke Fu who will take on the role of COO. Mr. Booth was also appointed to the board of directors of AUSA. With these two appointments and the recent appointment of Jon Paul as CFO of the Company, the core of the AUSA management team consists of highly successful industry veterans with a track record in value creation.

 

Terry Booth, CEO, stated, "With the completion of the ALPS transaction, AUSA has now been transformed into a revenue generating company with a difficult to imitate multi-state expansion strategy in the U.S. cannabis market. This transaction puts AUSA in a position where it can pursue novel streaming deals to fuel the scaling up of its high-quality brands across the nation, while delivering a de-risked income stream from a diversified services portfolio. We made a number of promises to our shareholders, and we are delivering on these, rapidly. I look forward to continuing a high-frequency dialogue with our stakeholders as we continue to execute and grow the Company. Ignite, excite and delight our shareholders and customers is not a corny phrase, it is our focus, it is our mission, it is our global and noble vision indeed."

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory